Chiodo, Tiziana,Hafner, Andreas,Hintermann, Tobias,Salvador, Beate,Szelagiewicz, Martin,Blatter, Fritz,Siebenhaar, Bernd,Vossen, Marcus
申请号:
AU2013276138
公开号:
AU2013276138A1
申请日:
2013.06.13
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula 1 (INN: Dasatinib) and a second compound selected from methyl-4-hydroxybenzoate, or nicotinamide, or ethyl gallate, or methyl gallate, or propyl gallate, or ethyl maltol or vanillin, or men- thol, or (1R,2S,5R)-(-)-menthol,as well as to a process for obtaining the same.